Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To comprehensively identify proteins interacting with 14-3-3 sigma in vivo, tandem affinity purification and the multidimensional protein identification technology were combined to characterize 117 proteins associated with 14-3-3 sigma in human cells. The majority of identified proteins contained one or several phosphorylatable 14-3-3-binding sites indicating a potential direct interaction with 14-3-3 sigma. 25 proteins were not previously assigned to any function and were named
SIP2
-26 (for 14-3-3 sigma-interacting protein). Among the 92 interactors with known function were a number of proteins previously implicated in oncogenic signaling (APC, A-RAF, B-RAF, and c-RAF) and cell cycle regulation (AJUBA, c-TAK, PTOV-1, and WEE1). The largest functional classes comprised proteins involved in the regulation of cytoskeletal dynamics, polarity, adhesion, mitogenic signaling, and motility. Accordingly ectopic 14-3-3 sigma expression prevented cellular migration in a wounding assay and enhanced
mitogen-activated protein kinase
signaling. The functional diversity of the identified proteins indicates that induction of 14-3-3 sigma could allow p53 to affect numerous processes in addition to the previously characterized inhibitory effect on G2/M progression. The data suggest that the cancer-specific loss of 14-3-3 sigma expression by epigenetic silencing or p53 mutations contributes to cancer formation by multiple routes.
...
PMID:Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. 1577 65
The symbiosis receptor kinase, SymRK, is required for root nodule development. A SymRK-interacting protein (
SIP2
) was found to form protein complex with SymRK in vitro and in planta. The interaction between SymRK and
SIP2
is conserved in legumes. The
SIP2
gene was expressed in all Lotus japonicus tissues examined.
SIP2
represents a typical plant mitogen-activated protein kinase kinase (MAPKK) and exhibited autophosphorylation and transphosphorylation activities. Recombinant
SIP2
protein could phosphorylate casein and the Arabidopsis thaliana
MAP kinase
MPK6. SymRK and
SIP2
could not use one another as a substrate for phosphorylation. Instead, SymRK acted as an inhibitor of
SIP2
kinase when MPK6 was used as a substrate, suggesting that SymRK may serve as a negative regulator of the
SIP2
signaling pathway. Knockdown expression of
SIP2
via RNA interference (RNAi) resulted in drastic reduction of nodules formed in transgenic hairy roots. A significant portion of
SIP2
RNAi hairy roots failed to form a nodule. In these roots, the expression levels of
SIP2
and three marker genes for infection thread and nodule primordium formation were downregulated drastically, while the expression of two other MAPKK genes were not altered. These observations demonstrate an essential role of
SIP2
in the early symbiosis signaling and nodule organogenesis.
...
PMID:A MAP kinase kinase interacts with SymRK and regulates nodule organogenesis in Lotus japonicus. 2235 70
Symbiosis receptor-like kinase (SymRK) is a key protein mediating the legume-Rhizobium symbiosis. Our previous work has identified an MAP kinase kinase,
SIP2
, as a SymRK-interacting protein to positively regulate nodule organogenesis in Lotus japonicus, suggesting that an
MAPK
cascade might be involved in Rhizobium-legume symbiosis. In this study, LjMPK6 was identified as a phosphorylation target of
SIP2
. Stable transgenic L. japonicus with RNAi silencing of LjMPK6 decreased the numbers of nodule primordia (NP) and nodule, while plants overexpressing LjMPK6 increased the numbers of nodule, infection threads (ITs), and NP, indicating that LjMPK6 plays a positive role in nodulation. LjMPK6 could interact with a cytokinin receptor, LHK1 both in vivo and in vitro. LjMPK6 was shown to compete with LHP1 to bind to the receiver domain (RD) of LHK1and to downregulate the expression of two LjACS (1-aminocyclopropane-1-carboxylic acid synthase) genes and ethylene levels during nodulation. This study demonstrated an important role of LjMPK6 in regulation of nodule organogenesis and ethylene production in L. japonicus.
...
PMID:An MAP kinase interacts with LHK1 and regulates nodule organogenesis in Lotus japonicus. 3069 31
The
mitogen-activated protein kinase
(
MAPK
) LjMPK6 is a phosphorylation target of
SIP2
, a
MAPK
kinase that interacts with SymRK (symbiosis receptor-like kinase) for regulation of legume-rhizobia symbiosis. Both LjMPK6 and
SIP2
are required for nodulation in
Lotus japonicus
. However, the dephosphorylation of LjMPK6 and its regulatory components in nodule development remains unexplored. By yeast two-hybrid screening, we identified a type 2C protein phosphatase, LjPP2C, that specifically interacts with and dephosphorylates LjMPK6 in vitro. Physiological and biochemical assays further suggested that LjPP2C phosphatase is required for dephosphorylation of LjMPK6 in vivo and for fine-tuning nodule development after rhizobial inoculation. A non-phosphorylatable mutant variant LjMPK6 (T224A Y226F) could mimic LjPP2C functioning in
MAPK
dephosphorylation required for nodule development in hairy root transformed plants. Collectively, our study demonstrates that interaction with LjPP2C phosphatase is required for dephosphorylation of LjMPK6 to fine tune nodule development in
L. japonicus
.
...
PMID:Dephosphorylation of LjMPK6 by Phosphatase LjPP2C is Involved in Regulating Nodule Organogenesis in
Lotus japonicus
. 3275 3